Levophed Injection, Solution, Concentrate
Product Images NDC 0409-3375
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levophed (NDC 0409-3375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Levophed 02)
Principal Display Panel (4 mL Vial Label)
This is a medication called Evophed, specifically Norepinephrine bitartrate. It comes in a single dose 5 mL vial and is meant for intravenous infusion only. The medication is distributed by Hospira, Inc. in Lake Forest, IL. It should be noted that it contains sulfites. There is some illegible text at the end.*
Principal Display Panel (4 mL Vial Carton)
This text is a product label for Levophed norepinephrine bitartrate injection. Each box contains 10 single-dose vials, each containing 4 mL of solution that must be diluted before use. The solution has a concentration of 4mg/4mL norepinephrine bitartrate and is meant for intravenous infusion only. The package insert has important information for usage, including warnings, dosage and dilution information, and storage conditions. Unused portions should be discarded, and the solution should be protected from light. The solution also contains sulfites.*
Principal Display Panel (4 mL Ampul Label)
Principal Display Panel (4 mL Ampul Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.